Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Xiromed
FDA Approves JAIMIESS — Xiromed LLC

Xiromed LLC secured FDA approval for JAIMIESS, the generic version of Levonorgestrel and Ethinyl Estradiol tablets, positioning the company to capture...

Sandoz
FDA Approves TIGECYCLINE — Sandoz Inc

Sandoz Inc. has received FDA approval for its generic intravenous formulation of tigecycline, increasing therapeutic availability and competing agains...

Cranbury
FDA Approves MORPHINE SULFATE — Cranbury Pharmaceuticals, LLC

Cranbury Pharmaceuticals, LLC secured FDA approval for its generic Morphine Sulfate oral formulation, granting the company a strategic foothold in the...

Fresenius
FDA Approves GLUCAGON — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC has received FDA approval for glucagon hydrochloride injection (NDA 201849), enabling the company to further expand its emerge...

Lupin
FDA Approves OXYCODONE HYDROCHLORIDE — Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals, Inc. received FDA approval for its Abbreviated New Drug Application #ANDA204603 to manufacture Oxycodone Hydrochloride on April...

ABBVIE
FDA Approves Unknown Drug — ABBVIE

U.S. regulators approved AbbVie’s **Humira** (adalimumab), the biopharmaceutical giant’s best-selling therapy, bringing the blockbuster drug to market...

BluePoint
FDA Approves CAPECITABINE — BluePoint Laboratories

BluePoint Laboratories announced the approval of oral capitolabine trading on Wednesday, adding a generic alternative to the market for cancer treatme...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS ELIZABETH

Sanofi has announced that its subsidiary, Actavis Elizabeth, has received final approval from the FDA for its generic drug, which is expected to竞争扩大该产...

FRESENIUS
FDA Approves Unknown Drug — FRESENIUS KABI USA

Fresenius Kabi USA announced its submission of an NDA for [Substance] on March 23, 2015, signaling a strategic move aimed at diversifying its portfoli...

QUAGEN
FDA Approves Unknown Drug — QUAGEN

QUAGEN announced FDA approval of its generic product and expects it to capture market share by providing a cost-effective alternative to the branded v...

Actavis
FDA Approves BUPRENORPHINE — Actavis Pharma, Inc.

Actavis Pharma has received approval for the ANDA090819 filing, expanding its portfolio with this generic sublingual buprenorphine HCl product, a form...

EISAI
FDA Approves Unknown Drug — EISAI INC

On February 13, 2015, Eisai Inc. received an FDA approval for a new drug application (NDA 206947), a development that is poised to significantly impac...

Pfizer
FDA Approves IBRANCE — Pfizer Laboratories Div Pfizer Inc

Pfizer received FDA approval for the oral breast cancer therapy Palbociclib (IBRANCE) on February 3, 2015, marking a significant entry into the rapidl...

Novartis
FDA Approves COSENTYX — Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals received FDA approval for Secukinumab (Cosentyx) on Jan. 21, 2015, a strategic milestone expected to bolster the company’s po...

Zydus
FDA Approves CARBIDOPA AND LEVODOPA — Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc. secured FDA approval for Carbidopa and Levodopa, providing a new oral generic option into the high-volume central nervo...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA

Teva Pharmaceutical received FDA approval for its Abbreviated New Drug Application (ANDA 202718) on December 29, 2014, enabling the generic launch of ...

Novo
FDA Approves SAXENDA — Novo Nordisk Pharmaceutical Industries, LP

Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Saxenda (liraglutide) in 2014, a GLP-1 agonist that entered the market to address...

E.R.
FDA Approves OPDIVO — E.R. Squibb & Sons, L.L.C.

The FDA has approved Opdivo (nivolumab) from E.R. Squibb & Sons, L.L.C., a key asset for the manufacturer's oncology franchise that is poised to bolst...

Carwin
FDA Approves POKONZA POTASSIUM CHLORIDE — Carwin Pharmaceutical Associates, LLC

Carwin Pharmaceutical Associates, LLC received FDA clearance for its potassium chloride oral formulation POKONZA, a move expected to expand generic su...

Merck
FDA Approves ZERBAXA — Merck Sharp & Dohme LLC

# FDA Approves Merck's ZERBAXA (Ceftolozane and Tazobactam) for Serious Bacterial Infections The FDA has approved Merck Sharp & Dohme LLC's ZERBAXA (...